FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/07/054789 [Registered on: 05/07/2023] Trial Registered Prospectively
Last Modified On: 16/09/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Siddha 
Study Design  Single Arm Study 
Public Title of Study   A Clinical trial on Arugampul veer kudeneer in the management of Kalladaippu (Urolithiasis) 
Scientific Title of Study   A PROSPECTIVE OPEN LABELLED, SINGLE ARM, NON RANDOMISED SINGLE CENTRIC, PHASE II CLINICAL TRIAL ON ARUGAMPUL VER KUDENEER IN THE MANAGEMENT OF KALLADAIPPU NOI(UROLITHIASIS) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr S Prema 
Designation  PG Scholar 
Affiliation  Government Siddha Medical College and Hospita 
Address  Department of Pothu Maruthuvam Government Siddha Medical College and Hospital Palayamkottai

Tirunelveli
TAMIL NADU
627002
India 
Phone  9790269215  
Fax    
Email  drprema1982@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Justus Antony MDS PhD 
Designation  Reder 
Affiliation  Government Siddha Medical College and Hospital 
Address  Department of Pothu Maruthuvam OPno10 Government Siddha Medical College Hospital Palayamkottai

Tirunelveli
TAMIL NADU
627002
India 
Phone  9443090849  
Fax    
Email  justusantony71@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Dr Manoharan MDS PhD 
Designation  professor and HOD 
Affiliation  Government Siddha Medical College ana Hospital 
Address  Department of Pothu Maruthuvam OPno10 Government Siddha Medical College and Hospital Palayamkottai

Tirunelveli
TAMIL NADU
627002
India 
Phone  9443886700  
Fax    
Email  drmanoharan25@gmail.com  
 
Source of Monetary or Material Support  
OPD and IPD facilities and Central Library of Government Siddha Medical College and Hospital 
 
Primary Sponsor  
Name  Government Siddha Medical College and Hospital 
Address  Government Siddha Medical College and Hospital Palayamkottai Tamil nadu 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr S Prema  Government Siddha Medical College and Hospital  PG Department of pothu Maruthuvam OPno10 Government Siddha Medical College and Hospital Palayamkottai
Tirunelveli
TAMIL NADU 
9790269215

drprema1982@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N209||Urinary calculus, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  ARUGAMPUL VEER KUDENEER  Dosage: 30-60 ml Frequency: twice a day Duration: 45 days 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient with the symptoms of Renal colicky pain
Loin to groin
pain
Nausea
Vomiting and sweating
Hematuria

Oliguria
Dysuria
 
 
ExclusionCriteria 
Details  Chronic Appendicitis
Cholecystitis
Pelvic inflammatory disease
Chronic Renal Failure
Bilateral obstructive uropathy 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduction in severity of Renal colicky pain,
Reduction of Nausea/vomiting
Reduction of Hematuria, Polyuria, Dysuria and
Oliguria.
The kidney stone is expelled to come out as
such or be disintegrated and mixed with urine
will be ensured. 
45 days 
 
Secondary Outcome  
Outcome  TimePoints 
The secondary outcome is reduction in size of
the kidney stone in USG abdomen and pelvis. 
45days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "40"
Final Enrollment numbers achieved (India)="40" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   21/07/2023 
Date of Study Completion (India) 05/07/2024 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a Prospective Open Labelled, Single arm, Non-Randomized, Single centric, Phase II 
clinical trial onARUGAMPUL VEER KUDENEER  in the management of KALLADAIPPU NOI(UROLITHIASIS)
The trial drug will be administered  orally at the dose of 30_60ml twice a day 45days along with as butteradjuvant in 40 patients. The trial period of 12 months will becarried out in Government Siddha Medical College and Hospital, Palayamkottai, Tirunelveli 627002 , Tamil nadu. The primary outcome will be the evaluation of therapeutic efficacy of the trial drug ARUGAMPUL VEER KUDENEER. The secondary outcome will be the evaluation of Siddha diagnostic  parameters,assessment of safety profile of trial drug, assessment of pharmacological and biochemical parameters of the trial drug. In case of any adverse events(AE) is noticed and it will be referred to pharmacovigilance department of SCRI. Further management of patients Will be given in OPD facility.
 
Close